HCA Holdings Inc. (HCA) Shares Bought by Robeco Institutional Asset Management B.V.
Robeco Institutional Asset Management B.V. raised its stake in shares of HCA Holdings Inc. (NYSE:HCA) by 24.9% during the third quarter, Holdings Channel reports. The fund owned 208,135 shares of the company’s stock after buying an additional 41,560 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in HCA Holdings were worth $15,742,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Magellan Asset Management Ltd acquired a new position in HCA Holdings during the second quarter valued at $489,097,000. Northwestern Mutual Investment Management Company LLC raised its position in HCA Holdings by 29.9% in the second quarter. Northwestern Mutual Investment Management Company LLC now owns 775,914 shares of the company’s stock valued at $59,753,000 after buying an additional 178,792 shares during the last quarter. Redwood Investments LLC raised its position in HCA Holdings by 24.6% in the second quarter. Redwood Investments LLC now owns 292,664 shares of the company’s stock valued at $22,538,000 after buying an additional 57,801 shares during the last quarter. DUPONT CAPITAL MANAGEMENT Corp raised its position in HCA Holdings by 7.1% in the second quarter. DUPONT CAPITAL MANAGEMENT Corp now owns 239,421 shares of the company’s stock valued at $18,438,000 after buying an additional 15,913 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its position in HCA Holdings by 48.2% in the second quarter. Nisa Investment Advisors LLC now owns 80,294 shares of the company’s stock valued at $6,183,000 after buying an additional 26,114 shares during the last quarter. 71.31% of the stock is currently owned by hedge funds and other institutional investors.
Shares of HCA Holdings Inc. (NYSE:HCA) traded down 0.426% during mid-day trading on Wednesday, reaching $71.215. The company’s stock had a trading volume of 631,793 shares. The company’s 50-day moving average is $76.23 and its 200 day moving average is $76.74. HCA Holdings Inc. has a 12 month low of $60.07 and a 12 month high of $83.69. The firm has a market cap of $26.68 billion, a price-to-earnings ratio of 11.274 and a beta of 0.79.
HCA Holdings (NYSE:HCA) last posted its earnings results on Thursday, October 27th. The company reported $1.61 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.42 by $0.19. The company earned $10.27 billion during the quarter, compared to analysts’ expectations of $10.41 billion. HCA Holdings had a net margin of 6.10% and a negative return on equity of 43.65%. HCA Holdings’s quarterly revenue was up 4.2% on a year-over-year basis. During the same period last year, the company posted $1.17 earnings per share. On average, equities analysts anticipate that HCA Holdings Inc. will post $6.71 EPS for the current year.
WARNING: This piece of content was reported by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international trademark and copyright law. The correct version of this piece of content can be accessed at http://www.dailypolitical.com/2016/11/30/hca-holdings-inc-hca-shares-bought-by-robeco-institutional-asset-management-b-v.html.
Several research analysts have weighed in on HCA shares. Zacks Investment Research lowered HCA Holdings from a “buy” rating to a “hold” rating in a research report on Tuesday, October 25th. Jefferies Group reaffirmed a “buy” rating on shares of HCA Holdings in a research report on Tuesday, September 6th. KeyCorp raised HCA Holdings from a “sector weight” rating to an “overweight” rating and set a $94.00 target price on the stock in a research report on Thursday, October 13th. Royal Bank Of Canada upped their target price on HCA Holdings from $88.00 to $95.00 and gave the stock an “outperform” rating in a research report on Friday, October 28th. Finally, Wolfe Research started coverage on HCA Holdings in a research report on Tuesday, October 25th. They issued an “outperform” rating on the stock. Nine investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $87.30.
In other HCA Holdings news, insider A Bruce Moore, Jr. sold 167,967 shares of the stock in a transaction on Wednesday, November 9th. The shares were sold at an average price of $73.65, for a total transaction of $12,370,769.55. Following the completion of the transaction, the insider now owns 207,682 shares in the company, valued at $15,295,779.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP P. Martin Paslick sold 36,004 shares of the stock in a transaction on Friday, October 28th. The shares were sold at an average price of $78.79, for a total transaction of $2,836,755.16. Following the transaction, the senior vice president now owns 35,894 shares of the company’s stock, valued at approximately $2,828,088.26. The disclosure for this sale can be found here. Company insiders own 3.10% of the company’s stock.
HCA Holdings Company Profile
HCA Holdings, Inc is a healthcare services company. The Company’s segment is operating hospitals and related healthcare entities. The Company operates approximately 168 hospitals, consisting of 164 general, acute care hospitals; three psychiatric hospitals, and one rehabilitation hospital. In addition, the Company operates approximately 116 freestanding surgery centers.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings Inc. (NYSE:HCA).
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.